- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SGMT
Recent news which mentions SGMT
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
July 24, 2025
From Benzinga
From Benzinga
Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps
June 04, 2025
From Benzinga
From Benzinga
This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
January 27, 2025
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 16, 2024
From Benzinga
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
December 16, 2024
From Benzinga
This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
November 12, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 01, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 01, 2024
From Benzinga
SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q2 2024
August 14, 2024
Tickers
SGMT
From InvestorPlace
From Benzinga
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
June 05, 2024
From Benzinga
From Benzinga
Tickers
SGMT
From InvestorPlace
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 25, 2024
From Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
From Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
From Benzinga
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 06, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
From Benzinga
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 26, 2024
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 26, 2024
From Benzinga
From InvestorPlace
KLA Reports Q2 Results, Joins Visa, Western Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session
January 26, 2024
From Benzinga
From InvestorPlace
Texas Instruments Reports Q4 Results, Joins BlackBerry And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 24, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.